Clinical Trials · NCT05898321
To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Enrollment
- 294
- Start date
- Jun 2023
- Locations
- 1 site, China
- Primary endpoint
- the remaining submucous fibroids volume